Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against a wave of cut-price competition to its top-selling medicines.

Sections:  world   
Topics:  europe   
RELATED ARTICLES
BING NEWS:
  • Latest lung cancer data could open new avenue for Roche’s Tecentriq
    Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives by an extra two months compared with chemotherapy in untreate...
    09/25/2018 - 11:19 pm | View Link
  • FDA extends review time for Roche’s Tecentriq/Avastin combo
    US regulators have extended the review period for Roche’s application to ... of metastatic non-squamous non-small cell lung cancer (NSCLC). The US Food and Drug Administration needs an extra three mon...
    09/5/2018 - 11:15 pm | View Link
  • Roche's Tecentriq adds two months to lung cancer patients' lives: study
    ZURICH (Reuters) - A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives ... Earlier this month, U.S. regulators extended their review of the immunotherapy ...
    01/31/2018 - 11:00 am | View Link
  • AbbVie/Roche’s Venclexta produces complete remission in 10% of hard-to-treat CLL patients
    Approved by the FDA in April and awaiting European approval in this patient group, the drug ... and other immunotherapy drugs are in development, (such as Novartis’ CLT019) and are now showing signs o...
    05/16/2016 - 1:00 pm | View Link
  • NHS patients barred from BMS' Opdivo, Roche's Kadcyla
    NICE is planning to bar patients with a particular form of lung cancer from access to Bristol-Myers Squibb’s ground-breaking immunotherapy Opdivo on the ... the Early Access to Medicines Scheme. The d...
    12/15/2015 - 5:45 pm | View Link
  • More
BING SEARCH:
  • Roche : Immunotherapy Drug Tecentriq Extended Patients ...
    By Noemie Bisserbe . Roche Holding AG said Thursday that its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, offering a new hope for patients and bolstering the Swiss drugmaker's defense against a wave of cut-price competition to its top-selling medicines.
    12/6/2018 - 3:02 am | View Website
  • Roche’s Immunotherapy Drug Tecentriq Extended Patients ...
    Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against ...
    12/2/2018 - 5:44 am | View Website
  • Immunotherapy Drug Extended Patients’ Lives – LIVING CORAM DEO
    Immunotherapy Drug Extended Patients’ Lives. Roche Holding AG said 21 December that its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, offering new hope for patients and bolstering the Swiss drugmaker’s defence against a wave of cut-price competition to its top-selling medicines.
    12/1/2018 - 12:30 am | View Website
  • Two Roche Cancer Drugs Get Disappointing Results | BioSpace
    In one study, combining Roche's immunotherapy drug Tecentriq with other standard cancer drugs extended by only about three weeks the median time patients with advanced squamous cell lung cancer lived before their disease progressed.
    11/29/2018 - 2:34 am | View Website
  • Two trial wins for Roche’s immunotherapy Tecentriq ...
    Roche’s immunotherapy Tecentriq (atezolizumab) has been shown to improve survival in lung cancer patients by almost five months in a new trial. Tecentriq plus chemotherapy boosted median overall survival to 18.6 months, compared to 13.9 months for chemotherapy alone.
    10/22/2018 - 6:42 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News